One capsule instead of a shelf of products.
One compounded capsule brings minoxidil, finasteride, biotin, and vitamin E into a single clinician-guided routine.
About 10 minutes. No charge unless your clinician approves.
One tablet. More than one prescribing decision.
Hair-loss treatment can become a routine-management problem almost as quickly as it becomes a medical one. One topical in the morning, another product at night, a tablet somewhere in between. The more pieces there are, the easier it is for the plan to quietly fall apart.
This compounded tablet consolidates minoxidil, finasteride, and biotin into one daily prescription.
The simplicity should not obscure what is inside it. Finasteride is an active prescription medication used in male pattern hair loss. Oral minoxidil is also pharmacologically active and makes cardiovascular and blood-pressure history relevant to the prescribing decision. Biotin is included in the compounded formula, but the combination does not need an inflated vitamin story to justify itself.
The real value is consolidation under medical supervision. Your clinician decides whether these components belong together for you, reviews the risks each active brings, and remains attached to the plan after the first shipment.
One capsule replaces a multi-product shelf. Each active has a named job, and your clinician interprets evidence from the individual components without treating it as proof for the finished compound.
Read the evidence →For men who want fewer steps, not less oversight.
The Consolidator
You would rather keep one daily tablet than manage multiple hair products across the day. The appeal is not more ingredients. It is fewer opportunities for the routine to fall apart.
The Topical-Fatigued
Scalp applications are not fitting your life, your hair, or your willingness to keep doing them indefinitely. You want to ask whether an oral plan is medically appropriate instead of forcing yourself through a routine you already dislike.
The Properly Screened Patient
You understand that oral minoxidil and finasteride bring real considerations with them. You want your cardiovascular history, blood pressure, medications, and sexual-side-effect concerns evaluated before convenience becomes the deciding factor.
Compounded by a licensed pharmacy and not an FDA-approved drug product. A licensed provider confirms candidacy, including cardiovascular history, from your full intake, and results vary.
This might not be the right fit if:
- Women who are or may become pregnant should not take or handle crushed or broken tablets
- Known cardiovascular conditions, without provider clearance
- Known hypersensitivity to finasteride, minoxidil, or biotin
- Existing depression or mood concerns, to be discussed with your provider first
- Uncontrolled blood pressure or a history of fluid retention
Your intake screens for all contraindications. Every candidate is evaluated by a licensed clinician before any prescription is issued. No prescription is issued without clearance.
Men's Oral Hair Compound, prescribed with care.
Compounded by a licensed 503A pharmacy. Prescribed by a licensed provider after clinical review.
- One compounded oral tablet containing minoxidil, finasteride, and biotin
- Prepared to your individual prescription by a licensed 503A pharmacy
- Taken on the schedule directed by your clinician
- Cardiovascular and medication history reviewed because oral minoxidil is part of the formula
- Response and tolerability followed through ongoing care
Prescription issued subject to provider judgment. Results vary. Not a guarantee of outcomes.
More in Beauty & Skin.
Glutathione
Antioxidant defense, under clinical direction.
Compounded injectable glutathione for clinician-guided antioxidant defense beyond the supplement aisle.
GHK-Cu Copper Peptide Cream
Prescription strength. Every percentage disclosed.
Prescription-compounded GHK-Cu cream in disclosed 2% and 4% strengths, not a mystery cosmetic complex.
Minoxidil
One daily tablet. Hair treatment out of sight.
One daily oral minoxidil tablet for people who want prescription hair care without a topical routine.
What the research shows
Finasteride 1 mg beat placebo on hair count at 12 and 24 months.
The detail
For the finasteride component: in two 1-year randomized, double-blind, placebo-controlled trials in 1553 men aged 18 to 41 with mild to moderate vertex hair loss, oral finasteride 1 mg daily produced a 107-hair difference from placebo within a 5.1 square centimeter circle of scalp at 12 months, and a 138-hair difference at 24 months.1
Finasteride cut the 5-year likelihood of developing further visible hair loss by 93 percent.
The detail
In an analysis of blinded global photographic assessment from those same two Phase III trials, finasteride 1 mg daily was associated with a 93 percent decrease relative to placebo in the 5-year likelihood of developing further visible hair loss, 95 percent confidence interval 89 to 97 percent.2
Oral minoxidil did not demonstrate superiority over topical minoxidil for terminal hair density.
The detail
For the oral minoxidil component: in a 24-week double-blind, double-dummy randomized clinical trial in 90 men aged 18 to 55 with androgenetic alopecia, of whom 68 completed, oral minoxidil 5 mg once daily did not demonstrate superiority over topical minoxidil 5 percent twice daily for terminal hair density, and hypertrichosis was reported in 49 percent of the oral group.3
Oral and topical minoxidil did not differ on hair density, but hypertrichosis was more common orally.
The detail
In a meta-analysis of four randomized clinical trials covering 279 patients with androgenetic alopecia followed for 24 to 39 weeks, oral and topical minoxidil did not differ in hair density or hair diameter, while hypertrichosis was significantly more common with the oral form, risk ratio 2.01, 95 percent confidence interval 1.18 to 3.41.4
In 1404 patients on low-dose oral minoxidil, hypertrichosis was the most frequent adverse effect.
The detail
In a retrospective multicenter study of 1404 patients treated with low-dose oral minoxidil for at least three months for any type of alopecia, hypertrichosis was the most frequent adverse effect at 15.1 percent, systemic effects included lightheadedness at 1.7 percent, fluid retention at 1.3 percent and tachycardia at 0.9 percent, and 1.2 percent stopped the drug because of adverse effects. The study had no control group.5
What it does not show
No trial has tested this tablet.
The detail
No trial has tested this tablet. There is no randomized controlled trial of minoxidil, finasteride and biotin combined in one compounded oral tablet, and no trial comparing that combination with finasteride alone, with oral minoxidil alone, or with placebo. Everything above is evidence for separate single agents at their own doses, and it does not transfer to the combination as sold.12345
No trial supports biotin for hair in people who are not biotin deficient.
The detail
Biotin is the component with the least behind it. A systematic review of the literature found 18 reported cases of hair or nail improvement with biotin, and in every one the patient had an underlying deficiency or a specific pathology; a second review found no clinical trial of biotin supplementation for alopecia of any kind and no randomized controlled trial of its effect on hair quantity or quality in humans. There is no evidence of benefit in people who are not biotin deficient.67
No randomized trial compares oral minoxidil plus oral finasteride against either drug on its own.
The detail
No randomized trial compares oral minoxidil plus oral finasteride against either drug on its own, so nothing establishes that the two actives are additive, or that the combination outperforms the better single agent. The argument for putting them in one tablet is an argument about adherence and convenience rather than a demonstrated efficacy gain.13
The single agents are approved medicines; this compounded tablet is not.
The detail
As single agents these are approved medicines: finasteride 1 mg is FDA-approved and used on label for male pattern hair loss, and minoxidil tablets are FDA-approved for hypertension and used off-label for hair. This tablet is neither of those things. It is compounded to an individual prescription, and no compounded preparation is FDA-approved, including this one.89
- Kaufman KD, et al. Finasteride in the treatment of men with androgenetic alopecia… J Am Acad Dermatol. 1998.
- Kaufman KD, Rotonda J, Shah AK, Meehan AG. Long-term treatment with finasteride 1 mg decreases the likelihood of… Eur J Dermatol. 2008.
- Penha MA, Miot HA, Kasprzak M, Muller Ramos P. Oral minoxidil vs topical minoxidil for male androgenetic alopecia: a… JAMA Dermatol. 2024.
- Sobral MVS, et al. Efficacy and safety of oral minoxidil versus topical solution in… Int J Dermatol. 2025.
- Vano-Galvan S, et al. Safety of low-dose oral minoxidil for hair loss: a multicenter study of… J Am Acad Dermatol. 2021.
- Patel DP, Swink SM, Castelo-Soccio L. A review of the use of biotin for hair loss. Skin Appendage Disord. 2017.
- Soleymani T, Lo Sicco K, Shapiro J. The infatuation with biotin supplementation: is there truth behind its… J Drugs Dermatol. 2017.
- FDA-approved prescribing information, PROPECIA (finasteride) tablets, Organon LLC, label published October 2024.DailyMed
- FDA-approved prescribing information, minoxidil tablets USP (oral), Par Health USA LLC, label published June 2026.DailyMed
Oral minoxidil's approved labeling covers much higher doses used for severe hypertension and carries a boxed warning about pericardial effusion progressing to tamponade and about worsening angina.
Do not use if you have
- Women who are or may become pregnant must not take this tablet or handle it crushed or broken, since finasteride can affect the development of a male fetus
Serious risks
- Postmarketing reports of breast tenderness and enlargement, testicular pain, depression and suicidal ideation
- Sexual dysfunction that continued after the drug was stopped
- Your provider notes that finasteride lowers PSA and can complicate prostate cancer screening
- Alongside the boxed warning, documented salt and water retention, faster heart rate and hair growth on the face and body
- The FDA has warned that biotin can interfere with laboratory immunoassays, including the troponin tests used to diagnose heart attacks, so any clinician ordering blood work needs to know you take it
Commonly reported
- Decreased libido
- Erectile dysfunction
- Ejaculation disorders
Finasteride is the component with the best-documented effects, and approved finasteride labeling records them in clinical trials. Oral minoxidil brings the cardiovascular questions, which is why blood pressure, cardiac history and current medications are reviewed before a hair dose is prescribed. Biotin is the quiet one, and the issue with it is not toxicity. The tablet is compounded to your individual prescription by a licensed 503A pharmacy and is not an FDA-approved drug product, and whether these three belong in one daily tablet is decided by a licensed provider who reviews the whole picture first.
Asked and answered.
You are not charged, and you are not left guessing. Your clinician explains the reasoning and, where it helps, what a better path might look like. Reviews are typically completed in under 24 hours.
They are genuinely worth knowing about. The finasteride in this compound can affect libido, erections, or ejaculation in a minority of men, and these deserve to be taken seriously. Most men are unaffected, and effects often resolve after stopping. Your provider will discuss the risk openly with you before you begin.
Because it is compounded to your prescription, pharmacy preparation happens after clinician approval. Any time, before your renewal date. No phone calls required.
Hair treatment works on a months-long horizon, and response varies. Continued use matters, but no specific result belongs on a guaranteed date. Your clinician reviews the trend over time and adjusts the plan from what is actually happening.